1. UBS Lux Equity Fund Biotech USD
UBS Lux Equity Fund Biotech USD P-acc
Fee
2.25%
ISIN
LU0069152568
Holdings
10
Fondsfinans Utbytte B
Fee
1.19%
ISIN
NO0013023234
Holdings
25
We have information about 14 holdings in UBS Lux Equity Fund Biotech USD, where the largest holding is Regeneron Pharmaceuticals (10.04), followed by Vertex (9.35) and Moderna (9.21). In comparison with Fondsfinans Utbytte, we have 29 holdings where DNB is the largest holding (5.92), followed by Orkla (5.28) and Schibsted (4.78).
Here we compare the holdings in UBS Lux Equity Fund Biotech USD and Fondsfinans Utbytte.
| UBS Lux Equity Fund Biotech USD | Fondsfinans Utbytte |
|---|---|
|
10.04 % |
 5.92 % |
|
9.35 % |
5.28 % |
|
9.21 % |
4.78 % |
|
6.96 % |
4.73 % |
 5.53 % |
4.69 % |
|
4.66 % |
4.57 % |
|
4.3 % |
4.08 % |
|
4.13 % |
4.02 % |
|
3.75 % |
3.76 % |
|
3.37 % |
3.57 % |
| - |
3.45 % |
| - |
3.43 % |
| - |
3.34 % |
| - |
3.21 % |
| - |
3.09 % |
| - |
3.06 % |
| - |
2.77 % |
| - |
2.48 % |
| - |
2.44 % |
| - |
2.42 % |
| - |
2.23 % |
| - |
2.21 % |
| - |
 2.01 % |
| - |
1.96 % |
| - |
1.95 % |
The list of fund holdings was last updated on June 5, 2025.
